Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The association between poverty and gene expression within peripheral blood mononuclear cells in a diverse Baltimore City cohort. | PLoS One | 2020 | 32970748 | PubTator, text mining | PubMed |
| Interactions Between Genome-Wide Genetic Factors and Smoking Influencing Risk of Systemic Lupus Erythematosus. | Arthritis Rheumatol | 2020 | 32969204 | PubTator, text mining | PubMed |
| A Remarkable Coexistence of Systemic Capillary Leak Syndrome and Diabetes in an 11-Year-Old Boy: A Case Report and Review of the Literature. | Case Reports Immunol | 2020 | 32953187 | PubTator, text mining | PubMed |
| Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma. | Signal Transduct Target Ther | 2020 | 32929063 | PubTator, text mining | PubMed |
| Kawasaki Disease: an Update. | Curr Rheumatol Rep | 2020 | 32924089 | PubTator, text mining | PubMed |
| Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors. | Explor Target Antitumor Ther | 2020 | 32924028 | PubTator, text mining | PubMed |
| Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma. | Oncoimmunology | 2020 | 32923142 | PubTator, text mining | PubMed |
| An Outbreak of Kawasaki-like Disease in children during SARS-CoV- 2 Epidemic: No Surprise? | Acta Biomed | 2020 | 32921711 | PubTator, text mining | PubMed |
| Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. | Gastroenterology | 2020 | 32918910 | PubTator, text mining | PubMed |
| Ponatinib and other CML Tyrosine Kinase Inhibitors in Thrombosis. | Int J Mol Sci | 2020 | 32911643 | PubTator, text mining | PubMed |
| Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations. | Molecules | 2020 | 32911607 | PubTator, text mining | PubMed |
| GO Nanosheets: Promising Nano Carrier for the S29, 1-(2-Chloro-2-(4-chlorophenyl-ethyl)-N-(4-fluorobenzyl)-1H-pyrazolo[3,4-d] pyrimidin-4-amine, Therapeutic Agent in Neuroblastoma. | Int J Mol Sci | 2020 | 32899395 | PubTator, text mining | PubMed |
| Common susceptibility loci in both systemic sclerosis and localized scleroderma identified using genetic analysis. | Chin Med J (Engl) | 2020 | 32889909 | PubTator, text mining | PubMed |
| Analysis of APPL1 Gene Polymorphisms in Patients with a Phenotype of Maturity Onset Diabetes of the Young. | J Pers Med | 2020 | 32854233 | PubTator, text mining | PubMed |
| Air Pollution and Atopic Dermatitis (AD): The Impact of Particulate Matter (PM10) on an AD Mouse-Model. | Int J Mol Sci | 2020 | 32846909 | PubTator, text mining | PubMed |
| Pseudohypertriglyceridemia: A Novel Case with Important Clinical Implications. | Case Rep Pediatr | 2020 | 32832184 | PubTator, text mining | PubMed |
| Systemic sclerosis pathogenesis: contribution of recent advances in genetics. | Curr Opin Rheumatol | 2020 | 32826477 | PubTator, text mining | PubMed |
| The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis. | Cancers (Basel) | 2020 | 32825035 | PubTator, text mining | PubMed |
| Three-Dimensional Interactions Analysis of the Anticancer Target c-Src Kinase with Its Inhibitors. | Cancers (Basel) | 2020 | 32824733 | PubTator, text mining | PubMed |
| Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2. | Cancers (Basel) | 2020 | 32824276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=47